<source id="q83sx"><mark id="q83sx"></mark></source>

<u id="q83sx"><sub id="q83sx"></sub></u><b id="q83sx"></b>
      <b id="q83sx"><tbody id="q83sx"><sub id="q83sx"></sub></tbody></b>
    1. <u id="q83sx"><small id="q83sx"></small></u>
      <var id="q83sx"><td id="q83sx"></td></var>
      <b id="q83sx"></b>
    2.  

      Relay Therapeutics

      1. ?Relay uncloaks with $57M Series A round to join the next-gen cancer race
      2. FierceBiotech's 2017 Fierce 15
      3. Relay Therapeutics Secures $400 Million in Series C Financing

       

      Nimbus Therapeutics

      1. ??Discovering Nimbus
      2. ?Nimbus Discovery Secures $24 Million Series A Financing
      3. ?Gilead Sciences Announces Acquisition of Nimbus Therapeutics’ Acetyl-CoA Carboxlyase (ACC) Program for NASH and Other Liver Diseases
      4. Nimbus Delivers Its Apollo Mission: A $1.2B Gilead Partnership
      5. Nimbus Therapeutics Announces $65 Million in New Financing to Accelerate Pipeline Progress and Expand Discovery Efforts

       

      Schrodinger

      1. ?Schr?dinger Announces Research Collaboration with Pfizer Inc
      2. Takeda, Schr?dinger form multiprogram drug discovery pact
      3. Schr?dinger, WuXi launch virtual drug discovery JV
      4. Schr?dinger Closes $85 Million Financing to Advance Computational Platform and Expand Drug Discovery Pipeline
      5. ?Schr?dinger Receives Clinical-Stage Milestone Payment from Sanofi Collaboration

       

      EpiTherapeutics

      1. Gilead Sciences Acquires EpiTherapeutics


      Constellation

      1. ?Constellation Pharmaceuticals and Genentech Enter Broad Epigenetics Drug Discovery Collaboration
      2. Constellation snags $100M 2 years after Genentech snub

       

      Epizyme

      1. ?Epizyme Gets $90M in Epigenetics Partnership with Celgene
      2. ?Boehringer Ingelheim and Epizyme Announce Worldwide Collaboration to Develop Novel Epigenetic Oncology Therapies
      3. Epizyme, Genentech Expand Cancer Combo Collaboration
      4. Strategic Collaborations

       

      Accent Therapeutics

      1. Accent Therapeutics Announces Company Launch with $40 Million Series A Financing for Novel, Precision Cancer Treatments Targeting RNA-Modifying Proteins

      欧美AAAAAA精品视频_亚洲午夜精品久久_无码免费有线在线观看_亚洲Av无码一又
      <source id="q83sx"><mark id="q83sx"></mark></source>

      <u id="q83sx"><sub id="q83sx"></sub></u><b id="q83sx"></b>
          <b id="q83sx"><tbody id="q83sx"><sub id="q83sx"></sub></tbody></b>
        1. <u id="q83sx"><small id="q83sx"></small></u>
          <var id="q83sx"><td id="q83sx"></td></var>
          <b id="q83sx"></b>